Mera Tilley, Ph.D.

Vice President, Head of Genetics

Professional Overview
Mera Tilley, Ph.D., is an accomplished executive with deep expertise in translational genetics, precision medicine, and clinical science. As the Vice President and Head of Genetics at Alumis, she leads a talented team in driving innovative genetic research and development to advance novel therapies. With a strong background in the biopharmaceutical industry, Mera has made significant contributions to the fields of quantitative genetics, precision medicine, and clinical science.

Experience Summary

Current Role
As the Vice President and Head of Genetics at Alumis, Mera is responsible for overseeing all aspects of the company's genetic research and development initiatives. She leads a team of talented scientists and researchers in identifying novel genetic targets, developing cutting-edge diagnostic tools, and designing personalized treatment strategies. Under Mera's guidance, Alumis has achieved several key milestones, including the successful launch of a first-in-class genetic therapy and the expansion of the company's genomic database.

Career Progression
Prior to joining Alumis, Mera held senior roles at leading biopharmaceutical companies, including Foresite Labs, Foresite Capital, Goldfinch Bio, and Pfizer. As the Senior Director of Translational Genetics at Foresite, she played a pivotal role in advancing the company's precision medicine portfolio, contributing to the development of several novel therapies. Mera's earlier experience at Pfizer as a Quantitative Geneticist and Senior Manager of Precision Medicine Clinical Scientist honed her expertise in applying genetic insights to clinical research and drug development.

Academic Background
Mera Tilley holds a Ph.D. in Genetics from the National Institutes of Health, where she conducted groundbreaking research on the genetic underpinnings of complex diseases. She also holds a Master's degree in Biotechnology from the University of Pennsylvania and a Bachelor's degree in Biology from the University of California, Berkeley.

Areas of Expertise

• Translational genetics and precision medicine

• Genetic target identification and validation

• Diagnostic and therapeutic biomarker development

• Clinical trial design and implementation

• Cross-functional team leadership and collaboration

Professional Impact
Throughout her career, Mera has made significant contributions to the field of genetics and precision medicine. She has authored numerous peer-reviewed publications, presented at industry conferences, and served as an advisor to several biotechnology startups. Mera's work has been instrumental in advancing the understanding of genetic factors in disease development and accelerating the development of personalized therapies.

Conclusion
With her extensive expertise, proven track record, and forward-thinking approach, Mera Tilley is a respected leader in the biopharmaceutical industry. As the Vice President and Head of Genetics at Alumis, she is poised to continue driving innovative genetic research and development, ultimately contributing to the improvement of patient outcomes and the advancement of the field of precision medicine.